体外受精市场－全球产业规模、份额、趋势、机会和预测，按技术、产品、卵子捐赠者、不孕症类型、应用、地区和竞争细分，2020-2030 年预测

2024 年全球体外受精市场规模为 284.1 亿美元，预计到 2030 年将达到 408.7 亿美元，预测期内的复合年增长率为 6.25%。市场成长的驱动力包括不孕症上升、辅助生殖技术进步、生育年龄延迟的趋势。体外受精 (IVF) 是一种被广泛采用的辅助生殖技术 (ART)，它涉及在体外使卵子与精子受精，然后将胚胎移植到子宫。 IVF 已帮助全球数百万人克服不孕不育。人口老化、生活方式改变和环境压力等因素导致不孕症上升，从而推动了对 ART 解决方案的需求。此外，IVF 程序的进步（例如改进的胚胎培养系统和个人化方案）提高了成功率。政府的支持性倡议、医疗保健服务的扩大以及公众意识的增强也使 IVF 更容易获得，尤其是在新兴经济体中，这些国家不断壮大的中产阶级和保险覆盖率进一步推动了市场应用。

关键市场驱动因素

全球不孕不育率上升

主要市场挑战

治疗费用高且难以取得

主要市场趋势

生育力保存的接受度不断提高

目录

第一章：服务概述

• 市场定义
• 市场范围
  • 覆盖市场
  • 考虑学习的年限
  • 主要市场区隔

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球体外受精市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依技术分类（ICSI IVF vs. 非 ICSI/传统 IVF）
  • 副产品（IVF培养基、ICSI机器、IVF孵化器、低温系统等）
  • 依卵子捐赠者分类（冷冻非捐赠者、新鲜非捐赠者、冷冻捐赠者、新鲜捐赠者）
  • 按不孕症（男性 vs. 女性）
  • 按应用（生育诊所、医院、其他）
  • 按地区
  • 按公司分类（2024）
• 产品图

第六章：北美体外受精市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲体外受精市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太体外受精市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲体外受精市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲体外受精市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球体外受精市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• The Fertility Center of Las Vegas
• Overlake Reproductive Health
• Gennet City Fertility
• Zita West Clinic
• Fertility Plus Clinic
• Nova IVF Centre and Fertility Clinic
• Bloom IVF Centre
• Progenesis Fertility Center
• Medicana IVF Center
• Medical Park Hospitals
• ART Fertility Clinics

第 16 章：策略建议

第17章调查会社について・免责事项

The Global In-Vitro Fertilization Market was valued at USD 28.41 billion in 2024 and is projected to reach USD 40.87 billion by 2030, growing at a CAGR of 6.25% during the forecast period. Market growth is driven by rising infertility rates, technological advancements in assisted reproduction, and the increasing trend of delayed parenthood. In-vitro fertilization (IVF), a widely adopted assisted reproductive technology (ART), involves fertilizing an egg with sperm outside the body and transferring the embryo to the uterus. IVF has helped millions worldwide overcome infertility. Factors such as aging populations, lifestyle changes, and environmental stressors are contributing to rising infertility, pushing demand for ART solutions. Furthermore, advancements in IVF procedures-like improved embryo culture systems and personalized protocols-have increased success rates. Supportive government initiatives, expanded healthcare access, and growing public awareness are also making IVF more accessible, particularly in emerging economies, where a growing middle class and insurance coverage are further driving market adoption.

Key Market Drivers

Rising Infertility Rates Globally

The increasing global prevalence of infertility is a primary driver of the IVF market. According to the World Health Organization (WHO), one in six individuals faces infertility during their lifetime. Contributing factors include delayed parenthood, lifestyle habits, stress, obesity, and environmental pollutants. Fertility declines significantly in women after age 35, while male infertility is also rising due to reduced sperm quality. Governments and healthcare systems are acknowledging this challenge by supporting access to fertility treatments. In Europe, several countries offer full or partial reimbursement for IVF, while awareness initiatives by NGOs and health agencies are breaking social stigmas and encouraging treatment. Additionally, improved healthcare infrastructure and insurance access in developing nations are further enabling IVF adoption among a broader population base.

Key Market Challenges

High Cost of Treatment and Limited Accessibility

Despite growing demand, the high cost of IVF treatment remains a significant barrier, especially in low- and middle-income countries. IVF procedures often require substantial financial investment, with multiple cycles sometimes needed to achieve success. In many regions, fertility treatments are not fully covered by insurance, limiting access to those with financial means. For example, in the United States, IVF is frequently excluded from standard insurance plans, making it less accessible. In contrast, countries like Israel and certain parts of Europe provide public funding, resulting in higher uptake rates. The lack of universal coverage and inconsistent reimbursement structures continue to restrict broader adoption of IVF services.

Key Market Trends

Growing Acceptance of Fertility Preservation

Fertility preservation is emerging as a notable trend in the IVF market. Procedures such as egg, sperm, and embryo freezing are gaining popularity among individuals postponing parenthood for personal, career, or medical reasons. This trend is supported by healthcare providers and employers alike, with some companies now including fertility preservation as part of employee benefits. Additionally, fertility preservation is increasingly integrated into cancer care, with guidelines from medical bodies like ASCO recommending early discussions on fertility options before treatment. As public awareness and social acceptance of assisted reproduction continue to rise, the appeal of fertility preservation is expanding the IVF user base beyond traditional infertility patients, indicating strong long-term growth potential.

Key Market Players

• The Fertility Center of Las Vegas
• Overlake Reproductive Health
• Gennet City Fertility
• Zita West Clinic
• Fertility Plus Clinic
• Nova IVF Centre and Fertility Clinic
• Bloom IVF Centre
• Progenesis Fertility Center
• Medicana IVF Center
• Medical Park Hospitals
• ART Fertility Clinics

Report Scope:

In this report, the Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

• ICSI IVF
• Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

• IVF Culture Media
• ICSI Machine
• IVF Incubators
• Cryo-System
• Others

In-Vitro Fertilization Market, By Egg Donor:

• Frozen non-donor
• Fresh non-donor
• Frozen Donor
• Fresh Donor

In-Vitro Fertilization Market, By Infertility:

• Male
• Female

In-Vitro Fertilization Market, By Application:

• Fertility Clinics
• Hospitals
• Others

In-Vitro Fertilization Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-Vitro Fertilization Market.

Available Customizations:

Global In-Vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
  • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
  • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
  • 5.2.4. By Infertility (Male v/s Female)
  • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Product
  • 6.2.3. By Egg Donor
  • 6.2.4. By Infertility
  • 6.2.5. By Application
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In-Vitro Fertilization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Egg Donor
      • 6.3.1.2.4. By Infertility
      • 6.3.1.2.5. By Application
  • 6.3.2. Canada In-Vitro Fertilization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Egg Donor
      • 6.3.2.2.4. By Infertility
      • 6.3.2.2.5. By Application
  • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Egg Donor
      • 6.3.3.2.4. By Infertility
      • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Product
  • 7.2.3. By Egg Donor
  • 7.2.4. By Infertility
  • 7.2.5. By Application
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France In-Vitro Fertilization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Egg Donor
      • 7.3.1.2.4. By Infertility
      • 7.3.1.2.5. By Application
  • 7.3.2. Germany In-Vitro Fertilization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Egg Donor
      • 7.3.2.2.4. By Infertility
      • 7.3.2.2.5. By Application
  • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Egg Donor
      • 7.3.3.2.4. By Infertility
      • 7.3.3.2.5. By Application
  • 7.3.4. Italy In-Vitro Fertilization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Egg Donor
      • 7.3.4.2.4. By Infertility
      • 7.3.4.2.5. By Application
  • 7.3.5. Spain In-Vitro Fertilization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Egg Donor
      • 7.3.5.2.4. By Infertility
      • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Product
  • 8.2.3. By Egg Donor
  • 8.2.4. By Infertility
  • 8.2.5. By Application
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China In-Vitro Fertilization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Egg Donor
      • 8.3.1.2.4. By Infertility
      • 8.3.1.2.5. By Application
  • 8.3.2. India In-Vitro Fertilization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Egg Donor
      • 8.3.2.2.4. By Infertility
      • 8.3.2.2.5. By Application
  • 8.3.3. Japan In-Vitro Fertilization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Egg Donor
      • 8.3.3.2.4. By Infertility
      • 8.3.3.2.5. By Application
  • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Egg Donor
      • 8.3.4.2.4. By Infertility
      • 8.3.4.2.5. By Application
  • 8.3.5. Australia In-Vitro Fertilization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Egg Donor
      • 8.3.5.2.4. By Infertility
      • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Product
  • 9.2.3. By Egg Donor
  • 9.2.4. By Infertility
  • 9.2.5. By Application
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Egg Donor
      • 9.3.1.2.4. By Infertility
      • 9.3.1.2.5. By Application
  • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Egg Donor
      • 9.3.2.2.4. By Infertility
      • 9.3.2.2.5. By Application
  • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Egg Donor
      • 9.3.3.2.4. By Infertility
      • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Product
  • 10.2.3. By Egg Donor
  • 10.2.4. By Infertility
  • 10.2.5. By Application
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Egg Donor
      • 10.3.1.2.4. By Infertility
      • 10.3.1.2.5. By Application
  • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Egg Donor
      • 10.3.2.2.4. By Infertility
      • 10.3.2.2.5. By Application
  • 10.3.3. UAE In-Vitro Fertilization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Egg Donor
      • 10.3.3.2.4. By Infertility
      • 10.3.3.2.5. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. The Fertility Center of Las Vegas
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Overlake Reproductive Health
• 15.3. Gennet City Fertility
• 15.4. Zita West Clinic
• 15.5. Fertility Plus Clinic
• 15.6. Nova IVF Centre and Fertility Clinic
• 15.7. Bloom IVF Centre
• 15.8. Progenesis Fertility Center
• 15.9. Medicana IVF Center
• 15.10. Medical Park Hospitals
• 15.11. ART Fertility Clinics

16. Strategic Recommendations

17. About Us & Disclaimer